• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Possible effects of anti-interleukin-17 agents on erythrodermic psoriasis with thymoma: A case report.

作者信息

Jia Qiuyu, Hu Jian, Zhang Jianzhong, Wang Xiaojie, Li Houmin

机构信息

Department of Dermatology, Peking University People's Hospital, Beijing, China.

出版信息

JAAD Case Rep. 2024 Mar 5;64:109-112. doi: 10.1016/j.jdcr.2024.02.018. eCollection 2025 Oct.

DOI:10.1016/j.jdcr.2024.02.018
PMID:40948685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12423661/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2006/12423661/e1a992223664/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2006/12423661/0033fa9da1b0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2006/12423661/15c0d9d6ce93/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2006/12423661/e1a992223664/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2006/12423661/0033fa9da1b0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2006/12423661/15c0d9d6ce93/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2006/12423661/e1a992223664/gr3.jpg

相似文献

1
Possible effects of anti-interleukin-17 agents on erythrodermic psoriasis with thymoma: A case report.抗白细胞介素-17药物对伴胸腺瘤的红皮病型银屑病的可能影响：一例报告
JAAD Case Rep. 2024 Mar 5;64:109-112. doi: 10.1016/j.jdcr.2024.02.018. eCollection 2025 Oct.
2
Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial.艾加莫德用于胸腺瘤相关重症肌无力的围手术期安全性和有效性：一项前瞻性、多中心、II期临床试验
J Thorac Oncol. 2025 Aug;20(8):1120-1130. doi: 10.1016/j.jtho.2025.04.014. Epub 2025 May 2.
3
Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics.基于血清蛋白质组学鉴定重症肌无力胸腺瘤的潜在预后生物标志物
Front Immunol. 2025 Jun 17;16:1580219. doi: 10.3389/fimmu.2025.1580219. eCollection 2025.
4
Efficacy and Safety of Adalimumab and Secukinumab in Erythrodermic Psoriasis: A Single Centre Retrospective Study.阿达木单抗和司库奇尤单抗治疗红皮病型银屑病的疗效与安全性：一项单中心回顾性研究
Indian J Dermatol. 2025 Jul-Aug;70(4):221. doi: 10.4103/ijd.ijd_1051_23. Epub 2025 Jun 30.
5
Strategies for Optimal Use of Biological Therapies in Managing Psoriasis: Focus on Secukinumab.银屑病管理中生物疗法的最佳使用策略：聚焦司库奇尤单抗
Dermatol Ther (Heidelb). 2025 Sep 4. doi: 10.1007/s13555-025-01515-x.
6
Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy.胸腺切除术后非胸腺瘤型与胸腺瘤型重症肌无力患者的预后及术后免疫治疗比较。
Ther Adv Neurol Disord. 2025 Jun 20;18:17562864251343573. doi: 10.1177/17562864251343573. eCollection 2025.
7
Erythrodermic Psoriasis: Excellent Management Avoiding Hospitalization.红皮病型银屑病：避免住院的卓越管理。
Acta Dermatovenerol Croat. 2024 Dec;32(4):214-216.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Development and Validation of an Artificial Intelligence-Driven Model for Accurate Classification of Erythrodermic Psoriasis Severity: Erythrodermic Psoriasis Integrated Classification System (EPICS).人工智能驱动的红皮病型银屑病严重程度准确分类模型的开发与验证：红皮病型银屑病综合分类系统（EPICS）
Am J Clin Dermatol. 2025 Aug 26. doi: 10.1007/s40257-025-00980-6.
10
Myasthenia gravis with Castleman disease: A case report with review of literature.重症肌无力合并卡斯特曼病：一例病例报告并文献复习
Indian J Pathol Microbiol. 2024 May 10. doi: 10.4103/ijpm.ijpm_482_23.

本文引用的文献

1
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review.用于红皮病型银屑病治疗的生物制剂：最新综述
Clin Cosmet Investig Dermatol. 2023 Aug 4;16:2045-2059. doi: 10.2147/CCID.S407813. eCollection 2023.
2
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis.司库奇尤单抗：中重度儿童斑块状银屑病治疗药物。
Paediatr Drugs. 2021 Nov;23(6):601-608. doi: 10.1007/s40272-021-00476-w. Epub 2021 Oct 19.
3
Clinical characteristics and outcomes of thymoma-associated myasthenia gravis.胸腺瘤相关重症肌无力的临床特征和结局。
Eur J Neurol. 2021 Jun;28(6):2083-2091. doi: 10.1111/ene.14820. Epub 2021 Mar 30.
4
Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis.胸腺瘤中 Th17 与 Tregs 的失衡可能是重症肌无力的病理机制。
Mol Immunol. 2021 May;133:67-76. doi: 10.1016/j.molimm.2021.02.011. Epub 2021 Feb 23.
5
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis.针对银屑病中 IL-23 和 IL-17 通路的治疗方法。
Lancet. 2021 Feb 20;397(10275):754-766. doi: 10.1016/S0140-6736(21)00184-7. Epub 2021 Jan 27.
6
Erythrodermic psoriasis: pathophysiology and current treatment perspectives.红皮病型银屑病：病理生理学及当前治疗观点
Psoriasis (Auckl). 2016;6:93-104. doi: 10.2147/PTT.S101232. Epub 2016 Jul 20.
7
Thymoma and thymic carcinomas.胸腺瘤和胸腺癌。
Crit Rev Oncol Hematol. 2016 Mar;99:332-50. doi: 10.1016/j.critrevonc.2016.01.012. Epub 2016 Jan 19.
8
Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.辅助性 T 细胞 17 型和 22 型在红皮病型银屑病和特应性皮炎中的免疫重叠。
JAMA Dermatol. 2015 Jul;151(7):753-60. doi: 10.1001/jamadermatol.2015.2.
9
Three cases of psoriasis vulgaris associated with myasthenia gravis.
J Dermatol. 2014 May;41(5):462-3. doi: 10.1111/1346-8138.12456.
10
Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course.皮肤病变中调节性 T 细胞减少：一种新描述的伴胸腺瘤多器官自身免疫性疾病的副肿瘤自身免疫紊乱，具有致命的临床病程。
Clin Exp Immunol. 2011 Nov;166(2):164-70. doi: 10.1111/j.1365-2249.2011.04472.x.